Pros and cons of pre-emptive screening programmes before peanut introduction in infancy

Area of Science:

• Allergy and Immunology
• Pediatric Health
• Public Health

Background:

• Peanut allergy is a significant public health issue with considerable psychosocial impact.
• While fatal anaphylaxis is rare, peanuts are a leading cause of food allergy-related mortality.
• The Learning Early About Peanut (LEAP) study demonstrated that early peanut introduction significantly reduces allergy risk in high-risk infants.

Purpose of the Study:

• To evaluate the benefits and drawbacks of pre-emptive screening before early peanut introduction in infants at high risk for peanut allergy.
• To compare US guidelines with international approaches regarding peanut allergy prevention strategies.
• To inform clinical practice and public health policy on infant feeding guidelines for peanut exposure.

Main Methods:

• Review of existing literature and clinical trial data, including the LEAP study.
• Analysis of guidelines from the US National Institute of Allergy and Infectious Diseases (NIAID) and other international bodies.
• Evaluation of screening methods such as peanut-specific IgE testing and skin prick tests.

Main Results:

• Early peanut introduction in high-risk infants (severe eczema or egg allergy) reduced peanut allergy by 81% at age 5.
• US guidelines recommend screening and potential oral food challenges before introduction for high-risk infants (aged 4-6 months).
• Contrasting international guidelines often do not advocate for population-level allergy screening before peanut introduction.

Conclusions:

• Early peanut introduction is a proven strategy for peanut allergy prevention.
• The necessity and approach to pre-emptive screening in high-risk infants remain a subject of debate between US and international guidelines.
• Further evaluation is needed to optimize screening strategies and ensure safe early introduction practices.